[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 1992

Increased Ventricular Response Rate During Exercise in Patients With Atrial Fibrillation Treated With Theophylline

Author Affiliations

From the Clinical Pharmacology and Gerontology Research Unit (Drs Dattilo and Vestal) and the Cardiology Section (Dr Eiriksson), Veterans Affairs Medical Center, Boise, Idaho; and Departments of Medicine (Drs Dattilo, Eiriksson, and Vestal) and Pharmacology (Dr Vestal), University of Washington, Seattle.

Arch Intern Med. 1992;152(4):797-803. doi:10.1001/archinte.1992.00400160095018

The effect of theophylline on atrioventricular conduction in atrial fibrillation was investigated by determining ventricular response rates at rest and during exercise treadmill tests in eight patients (mean [±SEM] age, 64.2±2.0 years) with chronic atrial fibrillation. Tests were performed before and after 7 days of oral theophylline treatment (plasma level, 87.7±7.8 µmol/L). There was no significant change in baseline ventricular rate or duration of exercise, but the maximum ventricular rate with theophylline treatment was 12.3%±2.4% higher than that with placebo (176.3± ±7.5 vs 158.1 ±8.8 beats per minute), and, during each stage of exercise, the ventricular rate with theophylline exceeded that with placebo. The increased heart rate during theophylline administration occurred without a significant difference in the exercise-induced increase in circulating plasma catecholamine levels. We conclude that treatment with theophylline may contribute to difficulties with rate control in acutely ill patients with coexisting atrial fibrillation.

(Arch Intern Med. 1992;152:797-803)